We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug That Combats Memory Loss in Alzheimer's Enters Phase II Trials

News   Sep 10, 2019 | Original story from the University at Buffalo

 
Drug That Combats Memory Loss in Alzheimer's Enters Phase II Trials
 
 
 

RELATED ARTICLES

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

Have a Cuppa While You Mull It Over

News

Regular tea drinkers have better organised brain regions – and this is associated with healthy cognitive function – compared to non-tea drinkers.

READ MORE

Perfecting a Method To Predict the Potential of New Drugs

News

Researchers are perfecting a method to predict the potential clinical implications of new drugs before clinical trials even start.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE